These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1715202)

  • 1. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
    Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
    Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
    Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis.
    Esteban JM; Yokota S; Husain S; Battifora H
    Am J Clin Pathol; 1990 Dec; 94(6):698-705. PubMed ID: 1700877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction between cells in serous effusions using a panel of antibodies.
    Lauritzen AF
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
    Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M
    Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
    Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
    Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
    Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
    Lung; 1995; 173(2):79-87. PubMed ID: 7536281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of epithelial membrane antigen in the work-up of problematic serous effusions.
    Singh HK; Silverman JF; Berns L; Haddad MG; Park HK
    Diagn Cytopathol; 1995 Jul; 13(1):3-7. PubMed ID: 7587872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
    Robinson RJ; Royston D
    Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study.
    Athanassiadou P; Gonidi M; Liossi A; Petrakakou E; Nakopoulou L; Zerva C; Athanassiades P
    Pathol Oncol Res; 2000; 6(2):100-3. PubMed ID: 10936783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.